Simplex Trading
BNGO icon

Simplex Trading’s Bionano Genomics BNGO Stock Holding History

Simplex Trading’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-14
Closed – – 8555
2024
Q4 		$0 Buy
+14
New +$239 ﹤0.01% 8533
2024
Q3 		– Sell
-492
Closed -$15.3K – 8511
2024
Q2 		$20K Buy
492
+265
+117% +$14.6K ﹤0.01% 6875
2024
Q1 		$15K Buy
+227
New +$16.9K ﹤0.01% 7310
2023
Q1 		– Sell
-85
Closed -$75.5K – 9044
2022
Q4 		$74K Buy
+85
New +$107K ﹤0.01% 5408
2022
Q1 		– Sell
-113
Closed -$153K – 10405
2021
Q4 		$202K Sell
113
-229
-67% -$612K ﹤0.01% 5175
2021
Q3 		$1.4M Buy
342
+31
+10% +$108K ﹤0.01% 2625
2021
Q2 		$1.37M Sell
311
-103
-25% -$407K ﹤0.01% 2678
2021
Q1 		$2M Buy
+414
New +$2.33M ﹤0.01% 1604

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Simplex Trading's BNGO Position: Q1 2025 in Review

Simplex Trading sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 14 shares.

Simplex Trading first reported a position in BNGO in Q1 2021 and held it in 8 quarters. The position peaked at $2M in Q1 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Simplex Trading reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 14 Bionano Genomics shares in Q1 2025.
  • Simplex Trading first reported a position in Bionano Genomics in Q1 2021 and held it in 8 quarters.
  • Simplex Trading's Bionano Genomics position peaked at $2M in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.